Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statins and stroke prevention.

Hashem M Shaltoni1, Frank M Yatsu, David C Hess

  • 1Department of Neurology, The University of Texas-Houston Medical School, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|June 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remote ischaemic conditioning in patients with supratentorial intracerebral haemorrhage (RICH-2): a multicentre, randomised, sham-controlled phase 3 trial in China.

EClinicalMedicine·2026
Same author

MAGEB16 as an epigenetic timing regulator linking X-chromosome biology to neurodevelopmental vulnerability in Autism Spectrum Disorder.

EXCLI journal·2026
Same author

Correction to: Creating Virtual Stroke Networks: Current and Future Role of Artificial Intelligence, Mobile Imaging Applications, and Telehealth in Triage and Treatment of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association.

Stroke·2026
Same author

Neuroinflammatory and functional outcomes after TBI are sex-dependent: Lessons from estrous-phase stratified female mice.

Neurochemistry international·2026
Same author

Author Correction: Methods for randomized, blinded, controlled evaluation of putative disease interventions in multilaboratory, preclinical assessment networks.

Lab animal·2026
Same author

Researcher photographs in recruitment materials to increase willingness to participate in brain health research.

Alzheimer's & dementia (New York, N. Y.)·2026
Same journal

Overview of Novel Mechanisms in Obesity Pharmacotherapy and Implications for Cardiovascular Disease: A Narrative Review.

Current atherosclerosis reports·2026
Same journal

Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.

Current atherosclerosis reports·2026
Same journal

Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.

Current atherosclerosis reports·2026
Same journal

Primary Prevention of Dyslipidemia: 10 Practice-Changing Takeaways from the 2026 ACC/AHA Multisociety Guideline.

Current atherosclerosis reports·2026
Same journal

Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.

Current atherosclerosis reports·2026
Same journal

Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.

Current atherosclerosis reports·2026
See all related articles

Statins show promise in preventing recurrent ischemic strokes, particularly for patients with atherosclerosis and abnormal cholesterol levels. Further research is ongoing to confirm their role in primary stroke prevention.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Coronary artery disease (CAD) studies suggest statins prevent cardiac events and ischemic strokes.
  • The role of statins in primary ischemic stroke prevention is not yet established.
  • Atherosclerosis is a key factor in ischemic stroke pathophysiology.

Purpose of the Study:

  • To review the pathophysiology of atherosclerosis.
  • To evaluate the evidence for statin use in preventing recurrent ischemic strokes.
  • To discuss the potential of statins in primary ischemic stroke prevention.

Main Methods:

  • Review of existing clinical trial data on statins in CAD.
  • Analysis of the pathophysiology of atheroma formation.
  • Discussion of pleiotropic effects of statins.

Related Experiment Videos

Main Results:

  • Statins are effective in preventing recurrent cardiac endpoints and ischemic strokes in CAD patients.
  • Clinicians can consider statins for recurrent ischemic stroke prevention in atherosclerosis patients with dyslipidemia.
  • The SPARCL study will provide data on primary stroke prevention.

Conclusions:

  • Statins are justified for averting recurrent ischemic strokes due to atherosclerosis.
  • Pleiotropic effects of statins may benefit ischemic stroke patients.
  • Further data are needed to confirm statins' efficacy in primary stroke prevention.